JEPCX | MENRX | JEPCX / MENRX | |
Total Expense Ratio | 1.35 | 0.91 | 148% |
Annual Report Gross Expense Ratio | 1.35 | 0.91 | 148% |
Fund Existence | 7 years | 13 years | - |
Gain YTD | 2.831 | 3.242 | 87% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 500000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.43B | 208M | 3,093% |
Annual Yield % from dividends | 7.52 | 7.82 | 96% |
Returns for 1 year | 9.00 | 5.27 | 171% |
Returns for 3 years | 29.60 | 27.80 | 106% |
Returns for 5 years | 65.03 | 67.17 | 97% |
Returns for 10 years | N/A | 73.83 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SWLGX | 127.20 | 1.43 | +1.14% |
Schwab ® US Large-Cap Growth Idx | |||
RYVFX | 9.96 | 0.08 | +0.81% |
Royce Small-Cap Value Service | |||
RNWFX | 90.05 | 0.56 | +0.63% |
American Funds New World R5 | |||
FQTEX | 13.36 | 0.04 | +0.30% |
Franklin Templeton SMACS: Series E Adv | |||
CSHCX | 8.72 | N/A | N/A |
NYLI Cushing® MLP Premier Class C |